Updates are available Correction dated 2025-12-11
Click to view Correction: https://doi.org/10.1186/s40658-025-00818-4
-
Authors
Hardiansyah, Deni
Riana, Ade
Hänscheid, Heribert
Jabar, Jaja Muhamad
Beer, Ambros J.
Lassmann, Michael
Glatting, Gerhard https://orcid.org/0000-0001-7916-1576
-
Funding
Funding for this research was provided by:
Universität Ulm
- License Information
-
More Information
Article History
Received: 3 June 2025
Accepted: 23 September 2025
First Online: 13 October 2025
Change Date: 11 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40658-025-00818-4
Declarations
:
: All patients provided informed consent for participation in this study. The study was conducted in compliance with the ethical standards outlined in the Declaration of Helsinki. Clinical trial registration was not applicable, and the study protocol was approved by the institutional review board (IRB).
: All authors read the manuscript and consented to its publication.
: DH and GG serve as independent consultants for ITM. ML reports institutional research grants from IPSEN Pharma, Nordic Nanovector, Novartis, and Pentixapharm.
